BME logo

Blackrock Health Sciences Trust (BME)

$42.20

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BME

AUM

$562653360

P/E ratio

--

Dividend yield

7.1874%

Expense ratio

1.08%

Beta

0.597564

Price on BME

Previous close

$41.81

Today's open

$41.77

Day's range

$41.61 - $42.50

52 week range

$34.18 - $42.63

Profile about BME

Headquarters

US

Exchange

New York Stock Exchange

Issue type

Common Stock

BME industries and sectors

Industries

Health

Top holdings in BME
News on BME

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

NEW YORK--(BUSINESS WIRE)---- $BBN--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), Bla.

news source

Business Wire • Jan 30, 2026

news preview

Switching From THQ To BME Despite The Yield

The abrdn Healthcare Opportunities Fund has delivered strong historical returns but now faces sustainability concerns due to leverage, premium to NAV, and likely fee waiver expiration. THQ's 11% yield is increasingly funded by return of capital, with NAV erosion and potential distribution cuts on the horizon. BlackRock Health Sciences Trust offers a safer alternative: a 7.5% yield, a conservative distribution policy, no leverage, a lower expense ratio, and currently trades at a 5.6% discount to NAV.

news source

Seeking Alpha • Jan 22, 2026

news preview

BME: Attractive Discount With Steady Monthly Distribution

BlackRock Health Sciences Trust has seen some strong performance recently, yet still trades at a -7.8% discount to NAV, offering compelling value. BME removed its options-writing strategy, eliminating upside caps and shifting focus to long-term capital appreciation in health sciences equities. Despite sector volatility and UNH headwinds, BME remains diversified in healthcare exposure, but some concentration in top holdings like LLY.

news source

Seeking Alpha • Dec 29, 2025

news preview

The Magnificent 7 Are So Yesterday. These Are AI's Next Big Winners

Today I have a sweet dividend “double shot” for you: The first? A 2.8% payout set to grow thanks to AI—and take the stock price up with it.

news source

Forbes • Dec 17, 2025

news preview

BME: Monthly Income With Upside From The Out-Of-Favor Healthcare Sector

I rate BlackRock Health Sciences Trust a Buy for income-focused investors seeking long-term, buy-and-hold exposure to blue-chip healthcare stocks. BME trades at a -7.8% discount to NAV and offers a monthly distribution yielding approximately 8%, supported by consistent, rising dividends. Recent political pressure on healthcare has depressed valuations, but I expect portfolio holdings like Eli Lilly and UnitedHealth to rebound as regulatory focus wanes.

news source

Seeking Alpha • Dec 15, 2025

news preview

3 Closed-End Fund Buys In October 2025

The broader equity indexes continue to look strong, led by mega-cap tech, which has helped push the markets to all-time highs. With hitting new all-time highs, I continue to allow my cash pile to build up instead of putting it all to work at what looks like elevated levels. That said, I make some purchases every month to help grow cash flow over time and to capitalize on pockets of opportunity.

news source

Seeking Alpha • Nov 14, 2025

news preview

B&M shares plunge after £7M accounting error forces earnings downgrade

Shares in B&M fell more than 19% on Monday after the UK discount retailer admitted a £7 million accounting error that will hit its earnings and trigger a leadership change. The company said that overseas freight costs were not correctly recognized in its accounts following an operating system update earlier this year.

news source

Invezz • Oct 20, 2025

news preview

BME: Attractively Valued But Weak NAV Growth

BlackRock Health Sciences Trust shares have declined 12.4% in the past year, underperforming the broader market rally. BME currently trades at an 8.3% discount to NAV, significantly wider than its five-year average discount of 2.48%. Despite an attractive 8.6% dividend yield, BME's low net investment income raises concerns about the sustainability of its distributions.

news source

Seeking Alpha • Oct 1, 2025

news preview

2 Call Writing Funds Providing Monthly Distributions For Passive Income

Call writing closed-end funds can offer attractive monthly distributions, along with the opportunity to trade at discounts to their historical net asset values. That discount can create an opportunity for investors to enter at attractive prices while getting the underlying portfolio on 'sale.' Today, we are looking at two CEFs that provide monthly distributions and are presenting relatively attractive discounts.

news source

Seeking Alpha • Sep 14, 2025

news preview

How To Invest $100,000 In A Near-Perfect Strategy Portfolio

Market timing is futile; a disciplined, diversified, and rules-based approach is essential for long-term investing success. A Near-Perfect Strategy portfolio aims for consistent income, growth, and lower volatility through diversification and strategic planning. The portfolio targets 6% income and S&P 500-beating returns, with lower volatility and drawdowns, making it suitable for investors seeking financial freedom or retirement income.

news source

Seeking Alpha • Aug 30, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Blackrock Health Sciences Trust

Open an M1 investment account to buy and sell Blackrock Health Sciences Trust commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BME on M1